Acyclic Triterpenoids from


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
12 Sep 2023
Historique:
received: 01 06 2023
accepted: 01 08 2023
medline: 18 9 2023
pubmed: 18 9 2023
entrez: 18 9 2023
Statut: epublish

Résumé

Cholesterol is one of the primary causes of cardiovascular disease. Investigating and developing potential drugs to effectively treat hypercholesterolemia are therefore of critical importance. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been developed to lower the levels of low-density lipoprotein cholesterol in patients with hypercholesterolemia. In this study, we aimed to identify compounds that inhibit the PCSK9 mRNA expression and secretion. The bioassay-guided investigation of

Identifiants

pubmed: 37720796
doi: 10.1021/acsomega.3c03873
pmc: PMC10500697
doi:

Types de publication

Journal Article

Langues

eng

Pagination

32804-32816

Informations de copyright

© 2023 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Molecules. 2020 Jul 23;25(15):
pubmed: 32717961
Angew Chem Int Ed Engl. 2022 Mar 21;61(13):e202117273
pubmed: 35072966
Nutrients. 2014 Dec 01;6(12):5517-33
pubmed: 25470376
Bioorg Chem. 2019 Mar;83:63-75
pubmed: 30342387
Curr Cardiol Rep. 2022 Nov;24(11):1657-1667
pubmed: 36087240
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Curr Atheroscler Rep. 2021 Jun 19;23(8):45
pubmed: 34146172
Vasc Endovascular Surg. 2016 Feb;50(2):107-18
pubmed: 26983667
Nat Prod Commun. 2012 Jun;7(6):795-8
pubmed: 22816310
Opt Express. 2022 Jun 20;30(13):22624-22636
pubmed: 36224955
Plant Foods Hum Nutr. 2015 Sep;70(3):257-62
pubmed: 25924694
Molecules. 2017 Sep 25;22(10):
pubmed: 28946703
Planta Med. 1999 Mar;65(2):196
pubmed: 17260260
Org Biomol Chem. 2012 Jun 7;10(21):4208-14
pubmed: 22543980
J Lipid Res. 2008 Jul;49(7):1595-9
pubmed: 18663786
Food Funct. 2014 Jun;5(6):1134-41
pubmed: 24722377
Org Lett. 2005 Jul 21;7(15):3303-6
pubmed: 16018646
J Nat Prod. 2011 Oct 28;74(10):2109-15
pubmed: 21942765
Nat Prod Res. 2017 Feb;31(4):487-491
pubmed: 27295355
Crit Rev Food Sci Nutr. 2021;61(2):325-336
pubmed: 32090592
Org Biomol Chem. 2023 Mar 29;21(13):2801-2808
pubmed: 36920451
Curr Opin Lipidol. 2014 Oct;25(5):387-93
pubmed: 25110901
Chirality. 2003 Nov;15(9):743-58
pubmed: 14556210
Biol Pharm Bull. 2012;35(11):2092-6
pubmed: 23123480
Nat Prod Res. 2022 Nov;36(22):5740-5746
pubmed: 34989299
Crit Rev Biochem Mol Biol. 2022 Apr;57(2):113-132
pubmed: 34601979
J Biol Chem. 2009 Oct 16;284(42):28885-95
pubmed: 19687008
Biosci Biotechnol Biochem. 2016 Jul;80(7):1425-32
pubmed: 26940726
Org Lett. 2021 Feb 5;23(3):1135-1140
pubmed: 33492976
Cell Mol Life Sci. 2003 Jun;60(6):1158-71
pubmed: 12861382
Nature. 2005 Dec 1;438(7068):612-21
pubmed: 16319881
ACS Omega. 2022 Jun 08;7(24):20952-20958
pubmed: 35755389
Chirality. 2013 Apr;25(4):243-9
pubmed: 23532998

Auteurs

Chae-Yeong An (CY)

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.

Min-Gyung Son (MG)

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.

Young-Won Chin (YW)

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.

Classifications MeSH